You are here: All Products  > China Medical Systems Invests $8 Million in Destiny; Will Acquire Asia Rights for MRSA Candidate

China Medical Systems Invests $8 Million in Destiny; Will Acquire Asia Rights for MRSA Candidate

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products